A Review of Four Practice Guidelines of Inflammatory Bowel Disease.

Autor:	Okobi OE; Family Medicine, Lakeside Medical Center, Belle Glade, USA., Udoete IO; Public Health, Central Michigan University, Mount Pleasant, USA., Fasehun OO; Internal Medicine, University College Hospital, Ibadan, NGA., Okobi T; Internal Medicine, Bronx Care Health System, New York, USA., Evbayekha EO; Isolation/Internal Medicine, Stella Obasanjo Isolation Center, Benin, NGA., Ekabua JJ; Infectious Disease, University of Louisville, Louisville, USA., Elukeme H; Internal Medicine, Floyd Medical Center, Rome, USA., Ebong IL; Internal Medicine, University of Ghana School of Medicine and Dentistry, Accra, GHA., Ajayi OO; Internal Medicine, Obafemi Awolowo College of Health Sciences, Olabisi Onabanjo University, Sagamu, NGA., Olateju IV; Internal Medicine, Washington Adventist University, Takoma Park, USA., Taiwo A; Internal Medicine/Health Information Management, Betsy Johnson Hospital, Dunn, USA., Anaya IC; Pathology and Laboratory Medicine, Ahmadu Bello University, Zaria, NGA., Omole JA; Internal Medicine, California Institute of Behavioral Neurosciences and Psychology, Fairfield, USA., Nkongho MB; Psychiatry, Saint James School of Medicine, Saint Vincent, VCT., Ojinnaka U; Family Medicine, Lankenau Medical Center, Wynnewood, USA., Ajibowo AO; Internal Medicine, Lugansk Medical University, Lugansk, UKR., Ogbeifun OE; Public Health, University of West Florida, Florida, USA., Ugbo OO; Oncology Research, Baylor Scott & White Health, Dallas, USA., Okorare O; Internal Medicine, Delta State University, Abraka, NGA., Akinsola Z; Internal Medicine, Windsor University School of Medicine, Toronto, CAN., Olusoji RA; Internal Medicine, St. Helens and Knowsley Teaching Hospitals National Health Service, Prescot, GBR., Amanze IO; Internal Medicine, Molly Specialist Hospital, Ibadan, NGA., Nwafor JN; Internal Medicine, University of the District of Columbia, Silver Spring, USA., Ukoha NA; Internal Medicine, Royal Cross Methodist Hospital, Abia, NGA., Elimihele TA; Clinical Research, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, USA.
Jazyk:	angličtina
Zdroj:	Cureus [Cureus] 2021 Aug 03; Vol. 13 (8), pp. e16859. Date of Electronic Publication: 2021 Aug 03 (Print Publication: 2021).
DOI:	10.7759/cureus.16859
Abstrakt:	Inflammatory bowel disease (IBD) is a term that encompasses conditions characterized by chronic inflammation of the gastrointestinal tract (GIT). It includes Crohn's disease and ulcerative colitis. Major scientific organizations interested in gastrointestinal systems or GIT-focused organizations worldwide release guidelines for diagnosing, classifying, managing, and treating IBD. However, there are subtle differences among each of these guidelines. This review evaluates four evidence-based guidelines in the management of IBD and seeks to highlight the differences and similarities between them. The main differences in the evaluated guidelines were in diagnosis and treatment recommendations. The diagnosing recommendations were comparable amongst the four guidelines; however, some were more specific about limiting the number of interventions necessary to confirm a diagnosis. Regarding treatment options, each guideline had clear suggestions about what was considered ideal. Although the treatment options were identical, the main differences existed in the recommended diets and initial therapy in patients with moderate disease. Clinical practice guidelines (CPGs) recommend evidence-based practice from opinion leaders in clinical decision-making. Rather than dictating a one-size-fits-all approach in IBD management, reviewing various guidelines can enhance the cross-pollination of ideas amongst clinicians to improve decision-making. Clearly describing and appraising evidence-based reasoning for scientific recommendations remain driving factors for quality patient care. The effectiveness of CPGs in improving health and the complexities of their formation requires constant review to maximize constructive criticisms and explore possible improvements. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2021, Okobi et al.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu